One year in review
Pathogenesis of rheumatoid arthritis: one year in review 2023
F.M. Mariani1, I. Martelli2, F. Pistone3, E. Chericoni4, I. Puxeddu5, A. Alunno6
- Department of Life, Health and Environmental Sciences, University of L’Aquila; Internal Medicine and Nephrology Division, ASL 1 Avezzano-Sulmona-L’Aquila, San Salvatore Hospital, L’Aquila, Italy.
- Immuno-Allergology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Immuno-Allergology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Immuno-Allergology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Immuno-Allergology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Department of Life, Health and Environmental Sciences, University of L’Aquila; Internal Medicine and Nephrology Division, ASL 1 Avezzano-Sulmona-L’Aquila, San Salvatore Hospital, L’Aquila, Italy. alessia.alunno82@gmail.com
CER16928
2023 Vol.41, N°9
PI 1725, PF 1734
One year in review
Free to view
(click on article PDF icon to read the article)
PMID: 37497721 [PubMed]
Received: 19/06/2023
Accepted : 29/06/2023
In Press: 24/07/2023
Published: 17/08/2023
Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterised by local and systemic inflammation. The complex interplay between immune cells and soluble mediators leads to the induction and perpetuation of aberrant inflammatory and autoimmune responses. The research carried out in the last year in the field of RA enabled the identification of new mechanisms involved in the pathogenesis of the disease and therefore unmasked new potential therapeutic targets. In this review article we summarised the new insights into RA pathogenesis from original research articles published in the last year.
